{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:52:32Z","timestamp":1792263152178,"version":"4.4.0"},"reference-count":74,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>(1) Background: Radiotherapy (RT) is a central component for the treatment of many head and neck cancers. In this systematic review of the literature, we aimed to characterize and quantify the published evidence on RT-related hypothyroidism, including estimated incidence, clinical risk factors, and dosimetric parameters that may be used to guide clinical decision making. Furthermore, we aimed to identify potential areas of improvement in the prevention and clinical management of RT-induced hypothyroidism, including the role of modern advanced therapeutic techniques. (2) Methods: We conducted a systemic review of the literature in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. PubMed and Google Scholar were searched to identify original research articles describing the incidence, mechanism, dosimetry, treatment, or prevention of radiation-related hypothyroidism for adults receiving RT for the treatment of head and neck cancers. The snowball method was used to identify additional articles. For identified articles, we tabulated several datapoints, including publication date, patient sample size, estimated hypothyroidism incidence, cancer site\/type, follow-up period, radiation modality and technique, use of multimodality therapy, method of thyroid function evaluation, and proposed dosimetric predictors of hypothyroidism. (3) Results: One hundred and eleven articles met inclusion criteria, reflecting a range of head and neck cancer subtypes. There was a large variation in the estimated incidence of RT-related hypothyroidism, with a median estimate of 36% (range 3% to 79%). Reported incidence increased in later publication dates, which was likely related to improved screening and longer follow up. There were a wide variety of predictive metrics used to identify patients at high risk of hypothyroidism, the most common of which were volumetric and mean dosimetrics related to the thyroid gland (Vxx%, Dmean). More recently, there has been increasing evidence to suggest that the thyroid gland volume itself and the volume of the thyroid gland spared from high-dose radiation (VSxx) may better predict thyroid function after RT. There were no identified studies investigating the role of advanced radiotherapeutic techniques such as MRI-guided RT or particle therapy to decrease RT-related hypothyroidism. Conclusions: Hypothyroidism is a common toxicity resulting from therapeutic radiation for head and neck cancer with recent estimates suggesting 40\u201350% of patients may experience hypothyroidism after treatment. Dosimetric predictive models are increasingly able to accurately identify patients at risk of hypothyroidism, especially those utilizing thyroid VS metrics. Further investigation regarding the potential for advanced radiotherapeutic therapies to decrease RT-induced thyroid dysfunction is needed.<\/jats:p>","DOI":"10.3390\/cancers15174321","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:09:49Z","timestamp":1693390189000},"page":"4321","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio"],"prefix":"10.3390","volume":"15","author":[{"given":"Michael K.","family":"Rooney","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Andring","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey L.","family":"Corrigan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bernard","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler D.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-3994","authenticated-orcid":false,"given":"Clifton D.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Garden","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Gunn","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6762-6807","authenticated-orcid":false,"given":"Amy C.","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5977-6004","authenticated-orcid":false,"given":"Jack","family":"Phan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spiotto","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/B:QURE.0000015315.35184.66","article-title":"Health-related quality of life in patients with thyroid disorders","volume":"13","author":"Bianchi","year":"2004","journal-title":"Qual. Life Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/eje.1.02124","article-title":"Quality of life in patients with benign thyroid disorders. A review","volume":"154","author":"Watt","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1210\/jc.2012-3375","article-title":"Excess Mortality in Patients Diagnosed with Hypothyroidism: A Nationwide Cohort Study of Singletons and Twins","volume":"98","author":"Thvilum","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/jamainternmed.2017.4836","article-title":"Association of Thyroid Function with Life Expectancy with and without Cardiovascular Disease: The Rotterdam Study","volume":"177","author":"Bano","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MED.0000000000000003","article-title":"When thyroid hormone replacement is ineffective?","volume":"20","author":"Benvenga","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1056\/NEJMcp1611144","article-title":"Subclinical Hypothyroidism","volume":"376","author":"Peeters","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, M., Tetzlaff, J., Altman, D.G., and PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wohlin, C. (2014, January 13\u201314). Guidelines for Snowballing in Systematic Literature Studies and a Replication in Software Engineering. Proceedings of the 18th International Conference on Evaluation and Assessment in Software Engineering, New York, NY, USA.","DOI":"10.1145\/2601248.2601268"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bmj.38636.593461.68","article-title":"Effectiveness and efficiency of search methods in systematic reviews of complex evidence: Audit of primary sources","volume":"331","author":"Greenhalgh","year":"2005","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/hed.23482","article-title":"Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: Prospective data from 2 randomized controlled trials","volume":"36","author":"Murthy","year":"2014","journal-title":"Head Neck"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.ijrobp.2012.05.020","article-title":"A Prospective Cohort Study on Radiation-induced Hypothyroidism: Development of an NTCP Model","volume":"84","author":"Boomsma","year":"2012","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2013.06.029","article-title":"Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: Normal tissue complication probability modeling with latent time correction","volume":"109","author":"Brink","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijrobp.2012.03.034","article-title":"Normal Tissue Complication Probability Modeling of Radiation-Induced Hypothyroidism after Head-and-Neck Radiation Therapy","volume":"85","author":"Bakhshandeh","year":"2013","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s12032-013-0710-9","article-title":"Hypothalamic\u2013pituitary\u2013thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma","volume":"30","author":"Huang","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1748-717X-9-104","article-title":"V30 as a predictor for radiation-induced hypothyroidism: A dosimetric analysis in patients who received radiotherapy to the neck","volume":"9","author":"Akgun","year":"2014","journal-title":"Radiat. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jjco\/hyt235","article-title":"Dose-volumetric Parameters for Predicting Hypothyroidism after Radiotherapy for Head and Neck Cancer","volume":"44","author":"Kim","year":"2014","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13014-014-0269-4","article-title":"Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy","volume":"9","author":"Chyan","year":"2014","journal-title":"Radiat. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jrr\/rrv006","article-title":"The threshold of hypothyroidism after radiation therapy for head and neck cancer: A retrospective analysis of 116 cases","volume":"56","author":"Fujiwara","year":"2015","journal-title":"J. Radiat. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3109\/0284186X.2014.1001034","article-title":"Variation of normal tissue complication probability (NTCP) estimates of radiation-induced hypothyroidism in relation to changes in delineation of the thyroid gland","volume":"54","author":"Brink","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_23","first-page":"257","article-title":"The incidence of hypothyroidism after radiotherapy for head and neck cancer","volume":"12","author":"Pil","year":"2016","journal-title":"B-ENT"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20160686","DOI":"10.1259\/bjr.20160686","article-title":"Nomogram for radiation-induced hypothyroidism prediction in nasopharyngeal carcinoma after treatment","volume":"90","author":"Luo","year":"2017","journal-title":"Br. J. Radiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.clon.2016.05.004","article-title":"Dosimetric Predictors of Hypothyroidism after Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma","volume":"28","author":"Lee","year":"2016","journal-title":"Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hed.24643","article-title":"Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation","volume":"39","author":"Ling","year":"2016","journal-title":"Head Neck"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijrobp.2017.03.007","article-title":"Thyroid V40 Predicts Primary Hypothyroidism after Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma","volume":"98","author":"Sommat","year":"2017","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oraloncology.2017.03.005","article-title":"Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study","volume":"68","author":"Zhai","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/COC.0000000000000165","article-title":"Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated with Intensity-modulated Radiotherapy (IMRT)","volume":"40","author":"Sachdev","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lin, Z., Yang, Z., He, B., Wang, D., Gao, X., Tam, S.-Y., and Wu, V.W.C. (2018). Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200310"},{"key":"ref_31","first-page":"6126","article-title":"A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma","volume":"16","author":"Xu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jrr\/rry036","article-title":"Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial","volume":"59","author":"Lertbutsayanukul","year":"2018","journal-title":"J. Radiat. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jnci.2018.01.004","article-title":"Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer","volume":"30","author":"Kotkat","year":"2018","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijrobp.2018.05.060","article-title":"Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients with Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiation Therapy","volume":"102","author":"McDowell","year":"2018","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Luo, R., Wu, V.W.C., He, B., Gao, X., Xu, Z., Wang, D., Yang, Z., Li, M., and Lin, Z. (2018). Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4348-z"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.adro.2019.08.006","article-title":"Radiation-Induced Hypothyroidism after Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma","volume":"5","author":"Kamal","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2478\/raon-2019-0055","article-title":"Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients","volume":"53","author":"Prpic","year":"2019","journal-title":"Radiol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1002\/cam4.2574","article-title":"Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy\u2014A single-institution study","volume":"8","author":"Huang","year":"2019","journal-title":"Cancer Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.meddos.2018.02.001","article-title":"Postradiation hypothyroidism in head and neck cancers: A Department of Veterans Affairs single-institution case-control dosimetry study","volume":"44","author":"Lin","year":"2019","journal-title":"Med. Dosim."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Peng, L., Mao, Y.-P., Huang, C.-L., Guo, R., Ma, J., Wen, W.-P., and Tang, L.-L. (2020). A New Model for Predicting Hypothyroidism after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.551255"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00066-020-01579-y","article-title":"Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy","volume":"196","author":"Matula","year":"2020","journal-title":"Strahlenther. Onkol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13014-020-01490-x","article-title":"Thyroid V50 is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: A retrospective study","volume":"15","author":"Zhou","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105378","DOI":"10.1016\/j.oraloncology.2021.105378","article-title":"Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose","volume":"120","author":"Zhu","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/00016489.2021.1998615","article-title":"Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer","volume":"141","author":"Inoue","year":"2021","journal-title":"Acta Oto-Laryngologica"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40644-022-00494-y","article-title":"Early post-treatment 18F-FDG PET\/CT for predicting radiation-induced hypothyroidism in head and neck cancer","volume":"22","author":"Lu","year":"2022","journal-title":"Cancer Imaging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13014-022-02028-z","article-title":"Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy","volume":"17","author":"Zhai","year":"2022","journal-title":"Radiat. Oncol."},{"key":"ref_47","first-page":"e31590","article-title":"Determining the Occurrence of Hypothyroidism following Treatment with Radiation Therapy in Head and Neck Carcinoma Patients and the Associated Role of Risk Factors and Dose-Volume Histograms: A Prospective Study","volume":"14","author":"Pal","year":"2022","journal-title":"Cureus"},{"key":"ref_48","first-page":"479","article-title":"Incidence of radiation-induced hypothyroidism following head and neck irradiation: A single-center analysis","volume":"27","author":"Assavanopakun","year":"2022","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2022.10.034","article-title":"Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose\u2013volume constraints with long-term endocrine outcomes","volume":"177","author":"Chow","year":"2022","journal-title":"Radiother. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijrobp.2016.04.004","article-title":"Free Thyroid Transfer: A Novel Procedure to Prevent Radiation-induced Hypothyroidism","volume":"96","author":"Harris","year":"2016","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/hed.24590","article-title":"Free thyroid transfer: Short-term results of a novel procedure to prevent post-radiation hypothyroidism","volume":"39","author":"Harris","year":"2016","journal-title":"Head Neck"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.amjoto.2018.12.013","article-title":"Free thyroid transfer to anterolateral thigh for prevention of radiation induced hypothyroidism: An initial experience","volume":"40","author":"Katna","year":"2018","journal-title":"Am. J. Otolaryngol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/srao.2002.31357","article-title":"A prospective, nonrandomized study of the impact of amifostine on subsequent hypothyroidism in irradiated patients with head and neck cancers","volume":"12","author":"Zoberi","year":"2002","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2006.08.051","article-title":"Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: A retrospective analysis of seventy-three patients","volume":"67","author":"Alterio","year":"2007","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_55","first-page":"417","article-title":"Computed Tomography Density Change in the Thyroid Gland before and after Radiation Therapy","volume":"38","author":"Ishibashi","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/thy.2010.0229","article-title":"A Longitudinal Study on the Radiation-Induced Thyroid Gland Changes after External Beam Radiotherapy of Nasopharyngeal Carcinoma","volume":"21","author":"Lin","year":"2011","journal-title":"Thyroid"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02685908","article-title":"Incidence of Hypothyroidism after Radiotherapy for Nasopharyngeal Carcinoma","volume":"24","author":"Ulger","year":"2007","journal-title":"Med. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/lio2.711","article-title":"Dysphagia, hypothyroidism, and osteoradionecrosis after radiation therapy for head and neck cancer","volume":"7","author":"Ranta","year":"2021","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ijrobp.2009.03.011","article-title":"Hypothyroidism after Radiotherapy for Nasopharyngeal Cancer Patients","volume":"76","author":"Wu","year":"2010","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00405-008-0797-3","article-title":"Detecting hypothyroidism after treatment for laryngeal or hypopharyngeal carcinomas: A nationwide survey in The Netherlands","volume":"266","author":"Galbo","year":"2008","journal-title":"Eur. Arch. Oto-Rhino-Laryngology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41415-022-5166-x","article-title":"Reviewing the epidemiology of head and neck cancer: Definitions, trends and risk factors","volume":"233","author":"Gormley","year":"2022","journal-title":"Br. Dent. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.15537\/smj.2021.42.3.20210660","article-title":"Radiation therapy in head and neck cancer","volume":"42","author":"Alfouzan","year":"2021","journal-title":"Saudi Med. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.soc.2012.12.001","article-title":"Multidisciplinary Care of the Patient with Head and Neck Cancer","volume":"22","author":"Saloura","year":"2013","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2018.03.003","article-title":"Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors after Intensity Modulated Versus 3-Dimensional Radiation Therapy","volume":"101","author":"Pinnix","year":"2018","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2022.10.013","article-title":"Late toxicity within a Phase III clinical trial of IG-IMRT in cervix cancer (PARCER): Reanalysis with time weighted adverse event reporting (MOSES)","volume":"177","author":"Supriya","year":"2022","journal-title":"Radiother. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijrobp.2021.09.042","article-title":"Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy","volume":"112","author":"Wortman","year":"2021","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2013.07.041","article-title":"Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the radiation therapy oncology group 0126 prostate cancer trial","volume":"87","author":"Michalski","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2012.07.001","article-title":"Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial","volume":"104","author":"Gupta","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: A review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"Oei","year":"2018","journal-title":"Radiat. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Thomas, H., and Timmermann, B. (2020). Paediatric proton therapy. Br. J. Radiol., 93.","DOI":"10.1259\/bjr.20190601"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.22.01148","article-title":"Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients with Solid Tumor Leptomeningeal Metastasis","volume":"40","author":"Yang","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semradonc.2017.12.002","article-title":"Comparing Intensity-Modulated Proton Therapy with Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey from Clinical Trial Concept to Activation","volume":"28","author":"Frank","year":"2018","journal-title":"Semin. Radiat. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4321\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:42:08Z","timestamp":1760128928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":74,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["cancers15174321"],"URL":"https:\/\/doi.org\/10.3390\/cancers15174321","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]}}}